Levothyroxine Use in the United States, 2008-2018

JAMA Intern Med. 2021 Oct 1;181(10):1402-1405. doi: 10.1001/jamainternmed.2021.2686.

Abstract

This cross-sectional study assesses national data for commercially insured and Medicare Advantage enrollees to analyze the use of levothyroxine in the US over time.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Asymptomatic Diseases* / epidemiology
  • Asymptomatic Diseases* / therapy
  • Cross-Sectional Studies
  • Drug Utilization / statistics & numerical data
  • Female
  • Humans
  • Hypothyroidism* / diagnosis
  • Hypothyroidism* / drug therapy
  • Hypothyroidism* / epidemiology
  • Insurance Claim Review
  • Male
  • Medical Overuse / prevention & control
  • Medicare / statistics & numerical data
  • Prescription Drugs / therapeutic use*
  • Thyroid Function Tests* / methods
  • Thyroid Function Tests* / statistics & numerical data
  • Thyroid Hormones / therapeutic use
  • Thyrotropin / blood
  • Thyroxine / therapeutic use*
  • United States / epidemiology

Substances

  • Prescription Drugs
  • Thyroid Hormones
  • Thyrotropin
  • Thyroxine